Newly released article on another company in the immunotherapy...

Newly released article on another company in the immunotherapy field.

http://seekingalpha.com/article/309610-immunocellular-the-potential-for-a-cancer-vaccine

Although the momentum has been lost for PRR recently due to market sentiment the feeling I get from all the articles and news about the field of immunotherapy is the sentiment is strongly favourable for the sector for those with a long term perspective.

For example the phase I trial results for ICT107 being described as "we think it’s a real phenomenon," "So I think what we’re seeing is really some pretty amazing outcomes,"

The risk reward ratio in the cancer immunotherapy sector is gradually swinging toward the reward IMHO.

Holding grimly.